In the case of MCT4, this is often attributed to a role in enabling the high fermentative glycolytic rates common in aggressive cancers, which hence enables tumor growth (Morais-Santos et al., 2015; Le Floch et al., 2011; Andersen et al., 2018). This evidence concerns the gene SLC16A3 and cancer.